학술논문

The utility of hyperbaric oxygen therapy in post-transplant cyclophosphamide-induced hemorrhagic cystitis: a case report and review of the literature.
Document Type
Journal Article
Source
Journal of Medical Case Reports. 1/4/2021, Vol. 15 Issue 1, p1-4. 4p.
Subject
*HYPERBARIC oxygenation
*BK virus
*CYSTITIS
*STEM cell transplantation
*CYCLOPHOSPHAMIDE
*GRAFT versus host disease
*HEMATOPOIETIC stem cell transplantation
Language
ISSN
1752-1947
Abstract
Background: To date, there are only a few case reports of cyclophosphamide (Cy)-induced hemorrhagic cystitis (HC) in adult or pediatric allogeneic stem cell transplant (SCT) patients treated successfully with hyperbaric oxygen (HBO). In all the reported cases, Cy was used as a part of the conditioning regimen, rather than post-transplant for graft-versus-host-disease (GVHD) prophylaxis. More recently, the risk of HC in allogeneic SCT is further increased by the widespread use of post-transplantation cyclophosphamide (PTCy) as a highly effective strategy for GVHD prophylaxis. This is the first case reported of PTCy-induced HC successfully treated with HBO to the best of our knowledge.Case Presentation: In this article, we present a 58-year-old Caucasian male case of allogeneic SCT complicated by severe HC following PTCy, which was successfully treated with HBO, eliminating the need for cystectomy.Conclusion: HBO can be a safe, noninvasive, alternative treatment modality for PTCy-induced HC developing in allogeneic SCT patients. [ABSTRACT FROM AUTHOR]